Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
Business|Economy|Health|Political
See Trump's announcement about obesity drug prices
The Trump administration announced deals that will lower the prices of major obesity drugs for many Americans. Under the deals with Eli Lilly and Novo Nordisk, those buying injectable GLP-1 medications directly from the companies will pay an average of $350 per month, but the drugmakers have committed to reducing the price to around $250 over the next two years, according to senior administration officials. If oral GLP-1 tablets are approved by the US Food and Drug Administration, the lowest dose will cost $149.
November 06, 2025
